Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Antibody targeting of claudin-1 as a potential colorectal cancer therapy

    Metastatic colorectal cancer (mCRC) is one of the major causes of cancer-related death. Despite the substantial progress in mCRC management, it remains important to identify new therapeutic options and biologi...

    S. Cherradi, A. Ayrolles-Torro, N. Vezzo-Vié in Journal of Experimental & Clinical Cancer … (2017)

  2. No Access

    Article

    Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy

    AXL receptor tyrosine kinase (RTK) is implicated in proliferation and invasion of many cancers, particularly in pancreatic ductal adenocarcinoma (PDAC), for which new therapeutic options are urgently required....

    W Leconet, C Larbouret, T Chardès, G Thomas, M Neiveyans, M Busson, M Jarlier in Oncogene (2014)

  3. No Access

    Article

    Reconstitution of regulatory T-cell subsets after allogeneic hematopoietic SCT

    Previous studies on regulatory T-cell (Treg) reconstitution after allogeneic hematopoietic SCT (HSCT) have suggested that, within the GVHD process, imbalance between effector T cells and Tregs may be more impo...

    A Xhaard, H Moins-Teisserenc, M Busson, M Robin, P Ribaud in Bone Marrow Transplantation (2014)

  4. No Access

    Article

    A low thymic function is associated with leukemia relapse in children given T-cell-depleted HLA-haploidentical stem cell transplantation

    E Clave, D Lisini, C Douay, G Giorgiani, M Busson, M Zecca, D Charron in Leukemia (2012)

  5. No Access

    Article

    Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders

    Combinations of HLA and killer immunoglobulin-like receptors (KIR) may affect outcome in T-cell depleted haematopoietic stem cell transplantation (HSCT). The KIR gene family includes inhibitory (KIR2DL and 3DL...

    C Chen, M Busson, V Rocha, M-L Appert, V Lepage, N Dulphy in Bone Marrow Transplantation (2006)

  6. No Access

    Article

    ERα and ERβ expression and transcriptional activity are differentially regulated by HDAC inhibitors

    The proliferative action of ERα largely accounts for the carcinogenic activity of estrogens. By contrast, recent data show that ERβ displays tumor-suppressor properties, thus supporting the interest to identify c...

    V Duong, A Licznar, R Margueron, N Boulle, M Busson, M Lacroix in Oncogene (2006)

  7. No Access

    Article

    Loss of the NPM1 gene in myeloid disorders with chromosome 5 rearrangements

    The assignment with chromosome banding techniques of the breakpoints of the recurrent translocation t(3;5) which leads to NPM1/MLF1 gene fusion in myeloid malignancies has not been unequivocal. In order to assess...

    R Berger, M Busson, L Baranger, C Hélias, M Lessard, N Dastugue, F Speleman in Leukemia (2006)

  8. No Access

    Article

    NUP214-ABL1 amplification in t(5;14)/HOX11L2-positive ALL present with several forms and may have a prognostic significance

    P Ballerini, M Busson, S Fasola, J van den Akker, H Lapillonne, S P Romana in Leukemia (2005)

  9. No Access

    Article

    Expression of the MN1–TEL fusion protein in the human UCSD/AML1 leukemic cell line

    V Della Valle, L Guglielmi, M Busson, E C Zwarthoff, R Berger, O A Bernard in Leukemia (2004)

  10. No Access

    Article

    t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH)

    To accurately estimate the incidence of HOX11L2 expression, and determine the associated cytogenetic features, in T-cell acute lymphoblastic leukemia (T-ALL), the Groupe Français de Cytogénétique Hématologique...

    R Berger, N Dastugue, M Busson, J van den Akker, C Pérot, P Ballerini in Leukemia (2003)

  11. No Access

    Article

    DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation

    In order to evaluate the impact of HLA-DBP1 incompatibilities on the occurrence of acute graft-versus-host disease (GVHD) in unrelated hematopoietic cell transplantation, we studied 57 donor/recipient pairs ch...

    P Loiseau, H Espérou, M Busson, R Sghiri, R Tamouza in Bone Marrow Transplantation (2002)

  12. No Access

    Article

    Epistasis between DSG1 and HLA class II genes in pemphigus foliaceus

    Pemphigus foliaceus (PF) is a rare and severe cutaneous autoimmune disease caused by autoantibodies directed against desmoglein 1 (DSG1), a desmosomal adhesion glycoprotein. We previously showed that the DSG1 ...

    P Martel, D Gilbert, M Busson, P Loiseau, V Lepage, L Drouot in Genes & Immunity (2002)

  13. No Access

    Article

    Identification of functional domains involved in BTG1 cell localization

    We have previously shown that BTG1 stimulates myoblast differentiation. In addition, this protein displays a major nuclear localization in confluent myoblasts, decreasing during the early steps of differentiat...

    A Rodier, P Rochard, C Berthet, J P Rouault, F Casas, L Daury, M Busson in Oncogene (2001)

  14. No Access

    Chapter

    The Follow up of the French Grafts

    From 1985 to 1994, the 103 french transplantation teams have operated 19910 grafts. We present the follow up of these organs from the data base of France Transplant which is an exhaustive registry of grafted p...

    Philippe Romano, M. Busson, J. Hors in Organ Shortage: The Solutions (1995)

  15. Article

    Life table analysis of the risk of Type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers

    To determine whether genetic markers can improve the predictive value of islet cell antibodies for development of Type 1 (insulin-dependent) diabetes mellitus, 536 siblings aged 2–29 years were consecutively e...

    I. Deschamps, C. Boitard, J. Hors, M. Busson, A. Marcelli-Barge, A. Mogenet in Diabetologia (1992)

  16. No Access

    Article

    A retrospective and prospective study of the number of kidney transplants in 31 countries

    The aim of the present study was to try to predict the number of cadaveric kidney transplantations (CKT) that will be performed in the year 1993. The raw data regarding the number of renal transplants that hav...

    C. Chevalier, J. M. Dupuy, M. Busson, J. Hors, G. Foulon in Transplant International (1989)

  17. No Access

    Article

    Multiple drug combinations with “low-dose” cyclosporin for renal transplantation

    The factors affecting graft survival in transplant recipients receiving cyclosporin (CsA) are still being debated. Our report is based on an analysis of 202 successive transplantations performed in our institu...

    C. Hiesse, P. Prevost, M. Busson, O. Lantz, M. Cantarovich in Transplant International (1988)

  18. Article

    Segregation of HLA-DR2 among affected and non-affected offspring of 66 families with Type 1 (insulin-dependent) diabetes

    Segregation of HLA-DR2 among affected and unaffected offspring was studied in 66 HLA-genotyped families with Type 1 diabetes in whom at least one parent carried DR2. The frequency of DR2-positive parents (21%)...

    I. Deschamps, I. Goderel, H. Lestradet, M. Schmid, M. Busson, D. Cohen in Diabetologia (1984)

  19. No Access

    Chapter and Conference Paper

    HLA and Familial Malignant Melanoma

    The aim of this work was to study a possible linkage between susceptibility to familial malignant melanoma (FMM) and the HLA region by geno- ty** multiplex-case families.

    J. Hors, F. Demenais, J. P. Cesarini, O. Verola in Histocompatibility Testing 1984 (1984)

  20. No Access

    Chapter and Conference Paper

    Antigen Report: HLA-Cw7

    The antigen Cw7 was first defined by Dehay et al. as CVE. They reported (a) that it was an allele of the HLA-C series; (b) that it was independent of HLA-A and B antigens in cap** experiments; (c) that gene ...

    V. Lepage, W. R. Mayr, M. Busson, L. Degos in Histocompatibility Testing 1984 (1984)

previous disabled Page of 2